This study aims to explore how ATM alleviates glycolipid metabolism and inflammatory stress in db/db mice and investigate its diabetes-related mechanisms in the pancreas, liver and intestine of mice by co-integrated analysis of metabolomics, microbiome and network pharmacology to provide evidence for its rational application in T2DM. Here, ATM is linked to type 2 diabetes mellitus.